This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65465353
rdf:type
wikibase:Item
schema:description
կլինիկական փորձարկում клінічне випробування ensayu clínicu clinical trial klinisch onderzoek
rdfs:label
CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease
skos:prefLabel
CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease
schema:name
CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease
p:P1476
wds:Q65465353-E6B8C22B-7076-4202-90E8-2EF33530C6F1
wdt:P1476
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease
p:P582
wds:Q65465353-58377E0D-AED0-45AB-A726-7D2CBF932A06
wdt:P582
2019-05-31T00:00:00Z
p:P31
wds:Q65465353-7F2B2C87-B88E-406F-9A23-805B47A3D912
wdt:P31
wd:Q30612
p:P580
wds:Q65465353-35D54A3B-3698-4EE2-A348-52F0922A20C5
wdt:P580
2016-03-22T00:00:00Z
p:P17
wds:Q65465353-FB5C1AD7-D1DA-478C-A64B-603A8DEB9EBD wds:Q65465353-F2814033-3FED-4EE3-B0B5-57D723E48FDB wds:Q65465353-F0A5E560-2051-4190-8EA9-6ED66AA86E7D wds:Q65465353-D646CBF1-5E0B-4E0F-BC48-A8857C329AA3 wds:Q65465353-D49F3AFC-8938-498C-970C-FFBA60ABEB70 wds:Q65465353-C245C0A6-FB70-492D-B890-379FAFA805C1 wds:Q65465353-B53FCAB6-0A12-4BE9-BC42-571951569B4B wds:Q65465353-B408A8E7-FF4F-45C7-BA81-CC8302F3356C wds:Q65465353-AD21E831-31C6-4AD9-99C1-085174F08055 wds:Q65465353-A2007261-B82D-42B4-AEB9-CB87653666C9 wds:Q65465353-92082AEA-1CD7-45D7-A011-A657EF2D34A1 wds:Q65465353-806F26ED-4219-4E84-839F-9F7B2AA8024A wds:Q65465353-7982237D-CE53-4B07-9E0F-2B78B663C5DD wds:Q65465353-7877F8A5-3DAA-406B-8BED-A42CE22477E1 wds:Q65465353-75656534-976B-46FE-A6FF-CABEDFBB0E43 wds:Q65465353-702291B3-53FE-4F9E-B927-E8BD3C5CE5BC wds:Q65465353-6A49568A-F7CE-43CA-AAF0-370D596CFA9C wds:Q65465353-5C2FAA81-FE3B-4799-963C-476CD8B5C595 wds:Q65465353-5C23B848-516D-46E8-AC0E-91B6FD291A1C wds:Q65465353-5334F17D-3D8B-4C14-8406-D2817F258566 wds:Q65465353-4F08F4B7-933C-4316-BA94-9A95274FC6AE wds:Q65465353-4E63DAE5-BFCA-47D1-A977-2473766F88D4 wds:Q65465353-386F5416-F0E7-4CB2-953E-2D1D7BF33535 wds:Q65465353-2D778150-9A4A-4B9F-AC1F-F6F7D83B1C5A wds:Q65465353-09F774AB-1E89-4BFE-8B95-F9783CCB0EAF wds:Q65465353-0661C0FF-FC27-43F1-9808-987F29A7F1E7
wdt:P17
wd:Q28 wd:Q37 wd:Q36 wd:Q38 wd:Q215 wd:Q39 wd:Q800 wd:Q35 wd:Q145 wd:Q29 wd:Q40 wd:Q219 wd:Q33 wd:Q183 wd:Q142 wd:Q45 wd:Q30 wd:Q34 wd:Q96 wd:Q212 wd:Q17 wd:Q16 wd:Q43 wd:Q224 wd:Q31 wd:Q408
p:P6153
wds:Q65465353-53DDAADB-B5D8-4D45-9731-3B2AB0D5CD60 wds:Q65465353-5E45BDE7-A33E-44F4-B855-BE110DED6457 wds:Q65465353-E01A0699-5680-4B51-9226-5321D3AE812B wds:Q65465353-F10DB8C2-6381-4C04-B1B3-8FD7A803D578 wds:Q65465353-F0B969D4-3036-41DE-87D6-058A2A04F7A5 wds:Q65465353-FA4CDC63-71D0-4865-8B49-A7B9B3D23C5D wds:Q65465353-29E79044-80BB-4AC7-A088-2BDAE79BE729 wds:Q65465353-28D098A0-8E3F-41C3-B69D-280591FBA146 wds:Q65465353-FFE009C0-3BB2-465B-9605-78C7A12F3F38 wds:Q65465353-A013DE16-34B1-41F2-B847-EB4DB45B4AE5 wds:Q65465353-AA196012-E221-4B23-9A4D-C0BF87AC4E40 wds:Q65465353-B03C5D79-FF84-4521-89CD-2E9E16D4102E wds:Q65465353-B147B64C-B5D5-4DA9-BA49-1960C9CE57E6 wds:Q65465353-B0958D33-2A74-409F-B4DC-DE7F32823846 wds:Q65465353-C0225F59-62FE-46F8-A137-415BA1392C4E wds:Q65465353-C0075F16-4499-45A3-9B5F-94B3CD112683 wds:Q65465353-C3584E7C-BCA6-485D-9598-27D51698864E wds:Q65465353-CEDB818F-03D4-4AA3-9A5A-7EB4CC54CF40 wds:Q65465353-C7945719-1D10-4DDE-906F-2D6AFD6274FB wds:Q65465353-5F8E33F2-26B9-4604-B882-C17A9F553DFB wds:Q65465353-695844FA-7E46-4347-AF5E-7B98B3E197EC wds:Q65465353-7D365490-38F9-4BCF-9D5E-472AE6A5CB8A wds:Q65465353-909E34B6-4F75-4A0D-BA26-A2A3C8C7084A wds:Q65465353-8F0852D9-282D-4F57-B63D-CF834EC3D142 wds:Q65465353-3F96F3F1-022F-47A2-8EFF-2EFBDF3634BD wds:Q65465353-5149DFF7-9038-486C-B793-568678C29E0C
wdt:P6153
wd:Q850730 wd:Q30269691 wd:Q1433199 wd:Q621043 wd:Q30269551 wd:Q1148210 wd:Q4863895 wd:Q1152942 wd:Q6806307 wd:Q2415975 wd:Q11421298 wd:Q1920549 wd:Q94198629 wd:Q7914205 wd:Q7826568 wd:Q61931487 wd:Q7914455 wd:Q3285348 wd:Q30270351 wd:Q11441079 wd:Q50035554 wd:Q30270062 wd:Q16188802 wd:Q30269718 wd:Q30287666 wd:Q30298472
p:P2899
wds:Q65465353-754C40F6-D110-4EBC-A128-0BF9330A1BFF
wdt:P2899
50
p:P131
wds:Q65465353-5D696E22-19E9-4725-85A6-BEA70E2872A3
p:P859
wds:Q65465353-5034DA01-20F6-4A5E-B0EC-F562482A927F
wdt:P131
wd:Q8646
wdt:P859
wd:Q212646
p:P1132
wds:Q65465353-32CB6C60-18FA-495A-9365-62B5F672E7B1
wdt:P1132
813
p:P4135
wds:Q65465353-E296E679-81DD-4EE8-A88C-3F7FCF25ADB1
wdt:P4135
85
p:P8363
wds:Q65465353-65987810-288C-487B-980E-021BBA4DE06A
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65465353-8D965254-75B3-4254-9974-F91CEA91576F
wdt:P3098
NCT02670083
p:P6099
wds:Q65465353-5F76A810-1C68-4666-AF5E-D88D945D9C39
wdt:P6099
wd:Q42824827